Dasatinib in Combination with BMS-754807 Induce Synergistic Cytotoxicity in Lung Cancer Cells through Inhibiting Lung Cancer Cell Growth, and Inducing Autophagy as Well as Cell Cycle Arrest at the G1 Phase

0
227
The authors demonstrated that dasatinib in combination with BMS-754807 inhibited lung cancer cell growth, while induced autophagy as well as cell cycle arrest at the G1 phase.
[Investigational New Drugs]
Abstract